E-Cigarette Flavors for Electronic Cigarette Use
Trial Summary
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications, but it excludes people with non-stable prescription medications. It's best to discuss your specific situation with the trial coordinators.
Is there any safety data on e-cigarette flavors?
How is the treatment with E-liquid Flavors 1, 2, and 3 different from other e-cigarette treatments?
This treatment is unique because it focuses on the use of specific e-liquid flavors, which can enhance the appeal and sensory experience of e-cigarette use, potentially influencing the initiation and maintenance of vaping. Unlike traditional tobacco products, these nontraditional flavors may also play a role in smoking cessation efforts.23678
What is the purpose of this trial?
The primary objective is to examine the influence of sex on sensory effects, appeal, and reinforcing value of nicotine containing e-cigs in popular flavor components; sweet and cooling.
Research Team
Danielle Davis
Principal Investigator
Yale University
Eligibility Criteria
This trial is for individuals aged 21-44 who currently smoke cigarettes and have used e-cigarettes at least 10 times in the past six months. Participants must be able to read/write, not planning to quit smoking soon, and willing to avoid nicotine/tobacco for 6-8 hours before lab sessions.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants sample 3 different flavored e-cigarettes containing nicotine in a human lab paradigm across 3 visits
Follow-up
Participants are monitored for sensory effects, appeal, and reinforcing efficacy immediately after intervention
Treatment Details
Interventions
- E-liquid Flavor 1
- E-liquid Flavor 2
- E-liquid Flavor 3
E-liquid Flavor 1 is already approved in European Union, United States for the following indications:
- Smoking cessation aid
- Smoking cessation aid
Find a Clinic Near You
Who Is Running the Clinical Trial?
Yale University
Lead Sponsor
National Institute on Drug Abuse (NIDA)
Collaborator